In $4 billion deal, Bristol Myers Squibb to buy cancer therapeutics firm RayzeBio

Biopharmaceutical company Bristol Myers Squibb announced Tuesday that it will acquire RayzeBio.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news